Maaike Berbee

Summary

Affiliation: University Hospital Maastricht
Country: The Netherlands

Publications

  1. ncbi Novel drugs to ameliorate gastrointestinal normal tissue radiation toxicity in clinical practice: what is emerging from the laboratory?
    Maaike Berbee
    Department of Radiation Oncology MAASTRO, GROW Research Institute, Maastricht University Medical Center, Maastricht, The Netherlands
    Curr Opin Support Palliat Care 6:54-9. 2012
  2. ncbi Novel strategies to ameliorate radiation injury: a possible role for tetrahydrobiopterin
    Maaike Berbee
    Department of Radiation Oncology MAASTRO, GROW Research Institute, Maastricht University Medical Center, Maastricht, The Netherlands
    Curr Drug Targets 11:1366-74. 2010

Detail Information

Publications2

  1. ncbi Novel drugs to ameliorate gastrointestinal normal tissue radiation toxicity in clinical practice: what is emerging from the laboratory?
    Maaike Berbee
    Department of Radiation Oncology MAASTRO, GROW Research Institute, Maastricht University Medical Center, Maastricht, The Netherlands
    Curr Opin Support Palliat Care 6:54-9. 2012
    ..To give an overview of promising novel agents under development for the prevention and reduction of gastrointestinal radiation injury...
  2. ncbi Novel strategies to ameliorate radiation injury: a possible role for tetrahydrobiopterin
    Maaike Berbee
    Department of Radiation Oncology MAASTRO, GROW Research Institute, Maastricht University Medical Center, Maastricht, The Netherlands
    Curr Drug Targets 11:1366-74. 2010
    ....